A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine

By Fuller T.E.   Thacker B.J.   Duran C.O.   Mulks M.H.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2867-2877

Elsevier

Access to resources Recommend Favorite

Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models

By Pratt W.D.   Davis N.L.   Johnston R.E.   Smith J.F.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3854-3862

Elsevier

Access to resources Recommend Favorite

Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers

By Vaughn D.W.   Hoke C.H.   Yoksan S.   LaChance R.   Innis B.L.   Rice R.M.   Bhamarapravati N.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 329-336

Elsevier

Access to resources Recommend Favorite

Potency testing of tissue culture rinderpest vaccine in rabbits

By Patil P.K.   Mondal B.   Goel A.C.   Sharma B.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 608-611

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

By Bernstein D.I.   Smith V.E.   Sherwood J.R.   Schiff G.M.   Sander D.S.   DeFeudis D.   Spriggs D.R.   Ward R.L.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 381-387

Elsevier

Access to resources Recommend Favorite